Grebow PE - Search Results

1

Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers.

Wong YN, King SP, Laughton WB, McCormick GC, Grebow PE. Wong YN, et al. Among authors: grebow pe. J Clin Pharmacol. 1998 Mar;38(3):276-82. doi: 10.1002/j.1552-4604.1998.tb04425.x. J Clin Pharmacol. 1998. PMID: 9549666 Clinical Trial.

2

Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers.

Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton W, Eldon R, Markland C, Grebow P. Wong YN, et al. J Clin Pharmacol. 1998 Oct;38(10):971-8. doi: 10.1002/j.1552-4604.1998.tb04395.x. J Clin Pharmacol. 1998. PMID: 9807980 Clinical Trial.

3

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P. Wong YN, et al. J Clin Pharmacol. 1999 Mar;39(3):281-8. J Clin Pharmacol. 1999. PMID: 10073328 Clinical Trial.

4

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC, Grebow PE. Wong YN, et al. Among authors: grebow pe. J Clin Pharmacol. 1999 Jan;39(1):30-40. doi: 10.1177/00912709922007534. J Clin Pharmacol. 1999. PMID: 9987698 Clinical Trial.

5

Pharmacokinetics and bioavailability of indapamide--a new antihypertensive drug.

Grebow PE, Treitman JA, Barry EP, Blasucci DJ, Portelli ST, Tantillo NC, Vukovich RA, Neiss ES. Grebow PE, et al. Eur J Clin Pharmacol. 1982;22(4):295-9. doi: 10.1007/BF00548396. Eur J Clin Pharmacol. 1982. PMID: 7106164 Clinical Trial.

6

The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders.

Lewis ME, Vaught JL, Neff NT, Grebow PE, Callison KV, Yu E, Contreras PC, Baldino F Jr. Lewis ME, et al. Among authors: grebow pe. Ann N Y Acad Sci. 1993 Aug 27;692:201-8. doi: 10.1111/j.1749-6632.1993.tb26218.x. Ann N Y Acad Sci. 1993. PMID: 8215023 Review. No abstract available.

7

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.

Lewis ME, Neff NT, Contreras PC, Stong DB, Oppenheim RW, Grebow PE, Vaught JL. Lewis ME, et al. Among authors: grebow pe. Exp Neurol. 1993 Nov;124(1):73-88. doi: 10.1006/exnr.1993.1177. Exp Neurol. 1993. PMID: 8282084 Review.

8

Pharmacokinetics of indapamide in dogs.

Grebow PE, Treitman JA. Grebow PE, et al. J Pharm Sci. 1981 Dec;70(12):1310-2. doi: 10.1002/jps.2600701205. J Pharm Sci. 1981. PMID: 7320842

9

Fluorometric assay for urinary indapamide.

Grebow PE, Treitman JA, Yeung AK. Grebow PE, et al. J Pharm Sci. 1978 Aug;67(8):1117-20. doi: 10.1002/jps.2600670824. J Pharm Sci. 1978. PMID: 671249

10

Lack of effect of bilateral nephrectomy on the pharmacokinetics of 14C-indapamide (REV 2555) and its metabolites in the dog.

Klunk LJ, Mangat S, Treitman JA, Grebow PE. Klunk LJ, et al. Among authors: grebow pe. Res Commun Chem Pathol Pharmacol. 1983 Nov;42(2):223-34. Res Commun Chem Pathol Pharmacol. 1983. PMID: 6658187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page